These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33112492)

  • 21. Protein prenylation: unique fats make their mark on biology.
    Wang M; Casey PJ
    Nat Rev Mol Cell Biol; 2016 Feb; 17(2):110-22. PubMed ID: 26790532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The chaperone protein SmgGDS interacts with small GTPases entering the prenylation pathway by recognizing the last amino acid in the CAAX motif.
    Schuld NJ; Vervacke JS; Lorimer EL; Simon NC; Hauser AD; Barbieri JT; Distefano MD; Williams CL
    J Biol Chem; 2014 Mar; 289(10):6862-6876. PubMed ID: 24415755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disruption of oncogenic K-Ras4B processing and signaling by a potent geranylgeranyltransferase I inhibitor.
    Lerner EC; Qian Y; Hamilton AD; Sebti SM
    J Biol Chem; 1995 Nov; 270(45):26770-3. PubMed ID: 7592913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific Disruption of Ras2 CAAX Proteolysis Alters Its Localization and Function.
    Ravishankar R; Hildebrandt ER; Greenway G; Asad N; Gore S; Dore TM; Schmidt WK
    Microbiol Spectr; 2023 Feb; 11(1):e0269222. PubMed ID: 36602340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ras farnesyltransferase: a new therapeutic target.
    Leonard DM
    J Med Chem; 1997 Sep; 40(19):2971-90. PubMed ID: 9301658
    [No Abstract]   [Full Text] [Related]  

  • 26. RhoB prenylation is driven by the three carboxyl-terminal amino acids of the protein: evidenced in vivo by an anti-farnesyl cysteine antibody.
    Baron R; Fourcade E; Lajoie-Mazenc I; Allal C; Couderc B; Barbaras R; Favre G; Faye JC; Pradines A
    Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11626-31. PubMed ID: 11027361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The carboxyl-terminal CXXX sequence of Gi alpha, but not Rab5 or Rab11, supports Ras processing and transforming activity.
    Cox AD; Graham SM; Solski PA; Buss JE; Der CJ
    J Biol Chem; 1993 Jun; 268(16):11548-52. PubMed ID: 8505289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enlarging the scope of cell-penetrating prenylated peptides to include farnesylated 'CAAX' box sequences and diverse cell types.
    Ochocki JD; Igbavboa U; Gibson Wood W; Wattenberg EV; Distefano MD
    Chem Biol Drug Des; 2010 Aug; 76(2):107-15. PubMed ID: 20584014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substrate characterization of the Saccharomyces cerevisiae protein farnesyltransferase and type-I protein geranylgeranyltransferase.
    Caplin BE; Hettich LA; Marshall MS
    Biochim Biophys Acta; 1994 Mar; 1205(1):39-48. PubMed ID: 8142482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of the farnesyl protein transferase inhibitor SCH66336 on isoprenylation and signalling by the prostacyclin receptor.
    O'Meara SJ; Kinsella BT
    Biochem J; 2005 Feb; 386(Pt 1):177-89. PubMed ID: 15469414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disrupting the transforming activity of shrimp ras(Q(61)K) by deleting the CAAX box at the C-terminus.
    Huang CF; Chen CH; Chuang NN
    J Exp Zool; 2001 Jun; 289(7):441-8. PubMed ID: 11351331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pseudodipeptide inhibitors of protein farnesyltransferase.
    deSolms SJ; Deana AA; Giuliani EA; Graham SL; Kohl NE; Mosser SD; Oliff AI; Pompliano DL; Rands E; Scholz TH
    J Med Chem; 1995 Sep; 38(20):3967-71. PubMed ID: 7562930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic Ras signaling by inducing cytoplasmic accumulation of inactive Ras-Raf complexes.
    Lerner EC; Qian Y; Blaskovich MA; Fossum RD; Vogt A; Sun J; Cox AD; Der CJ; Hamilton AD; Sebti SM
    J Biol Chem; 1995 Nov; 270(45):26802-6. PubMed ID: 7592920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thematic review series: lipid posttranslational modifications. CAAX modification and membrane targeting of Ras.
    Wright LP; Philips MR
    J Lipid Res; 2006 May; 47(5):883-91. PubMed ID: 16543601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The CaaX specificities of Arabidopsis protein prenyltransferases explain era1 and ggb phenotypes.
    Andrews M; Huizinga DH; Crowell DN
    BMC Plant Biol; 2010 Jun; 10():118. PubMed ID: 20565889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a novel prenyl and palmitoyl modification at the CaaX motif of Cdc42 that regulates RhoGDI binding.
    Nishimura A; Linder ME
    Mol Cell Biol; 2013 Apr; 33(7):1417-29. PubMed ID: 23358418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prenylated c17orf37 induces filopodia formation to promote cell migration and metastasis.
    Dasgupta S; Cushman I; Kpetemey M; Casey PJ; Vishwanatha JK
    J Biol Chem; 2011 Jul; 286(29):25935-46. PubMed ID: 21628459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and synthesis of non-peptide Ras CAAX mimetics as potent farnesyltransferase inhibitors.
    Qian Y; Vogt A; Sebti SM; Hamilton AD
    J Med Chem; 1996 Jan; 39(1):217-23. PubMed ID: 8568811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bisubstrate inhibitors of farnesyltransferase: a novel class of specific inhibitors of ras transformed cells.
    Manne V; Yan N; Carboni JM; Tuomari AV; Ricca CS; Brown JG; Andahazy ML; Schmidt RJ; Patel D; Zahler R
    Oncogene; 1995 May; 10(9):1763-79. PubMed ID: 7753553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of insulin on farnesyltransferase activity in 3T3-L1 adipocytes.
    Goalstone ML; Draznin B
    J Biol Chem; 1996 Nov; 271(44):27585-9. PubMed ID: 8910345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.